Safety And Treatment Adherence With Acalabrutinib In Very Old (>=80Y) And/Or Frail Patients With Chronic Lymphocytic Leukemia (Cll) - Interim Safety Analysis Of The Ongoing Phase-Ii Cll-Frail Trial
Acalabrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety And Treatment Adherence With Acalabrutinib In Very Old (>=80Y) And/Or Frail Patients With Chronic Lymphocytic Leukemia (Cll) - Interim Safety Analysis Of The Ongoing Phase-Ii Cll-Frail Trial ### Output: Acalabrutinib